METTL3 and head and neck squamous cell carcinoma: Mechanistically, METTL3 acts as an oncogene to promote cell proliferation, migration, invasion, and angiogenesis in HNSCC through the m6A-mediated upregulation of CDC25B (Fig. 6J).